Your browser doesn't support javascript.
loading
Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer.
Reizine, Natalie; Socco, Samantha; Weng, Eric; Atueyi, Uka; Mehta, Vikas; Patnaik, Akash.
Afiliación
  • Reizine N; Division of Hematology and Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL.
  • Socco S; College of Pharmacy, The University of Illinois at Chicago, Chicago, IL.
  • Weng E; Division of Hematology and Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL.
  • Atueyi U; Department of Radiology, The University of Illinois at Chicago, Chicago, IL.
  • Mehta V; Department of Pathology, The University of Illinois at Chicago, Chicago, IL.
  • Patnaik A; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL.
JCO Precis Oncol ; 7: e2200483, 2023 03.
Article en En | MEDLINE | ID: mdl-36996374
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article